Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2018 / N 1

Бронхиальная астма с поздним началом: возможности персонифицированной терапии
А.А. Визель, И.Ю. Визель

References
1. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). Updated 2018. Availble from: http://www.ginasthma.org Accessed 2018 May 18.
2. Russian respiratory society. Pediatric respiratory society. Federal clinical guidelines for the diagnosis and treatment of asthma. Moscow; 2016. Available from: www.spulmo.ru. Accessed 2018 May 18 (In Russian).
3. Pavord ID, Mathieson N, Scowcroft A, Pedersini R, Isherwood G, Price D. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis. NPJ Primary Care Respiratory Medicine 2017 Mar 9;27(1):17.
4. Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, Wagener AH, Wagers SS, Sterk PJ, Compton CH; Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome (U-BIOPRED) Consortium, Consensus Generation. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011 Oct;66(10):910-7.
5. Kurbacheva OM, Pavlova KS. Phenotypes and endotypes of bronchial asthma: from pathogenesis and clinical features to therapy. Russian Journal of Allergology 2013;1:15-24 (In Russian).
6. Kudelya LM, Sidorova LD, Mozhina LN, Tikhomirova EG, Manzhileeva TV. Influence of bronchial asthma debut on its course clinical functional peculiarities. Bulletin of the Siberian branch of the Russian Academy of Medical Sciences 2014;34(6):82-7 (In Russian).
7. Shaporova N, Trofimov V, Pelevina I, Yablonskaya V, Baranova O. Late-onset asthma: specific features of its clinical presentation and management tactics in outpatient settings. Vrach (The Doctor) 2013;2:22-4 (In Russian).
8. Ayres JG. Late onset asthma. British Medical Journal 1990 Jun 23;300(6740):1602-3.
9. Hirano T, Matsunaga K. Late-onset asthma: current perspectives. Journal of Asthma and Allergy 2018 Feb 9;11:19-27.
10. Sin BA, Akkoca O, Saryal S, Oner F, Misirligil Z. Differences between asthma and COPD in the elderly. Journal of Investigational Allergology & Clinical Immunology 2006;16(1):44–50.
11. Choi S, Hoffman EA, Wenzel SE, Castro M, Fain S, Jarjour N, Schiebler ML, Chen K, Lin CL; National Heart, Lung and Blood Institute’s Severe Asthma Research Program. Quantitative computed tomographic imaging-based clustering differentiates asthmatic subgroups with distinctive clinical phenotypes. Journal of Allergy and Clinical Immunology 2017 Sep;140(3):690-700.e8.
12. Ulrik CS. Late-onset asthma: a diagnostic and management challenge. Drugs & Aging 2017 Mar;34(3):157-62.
13. Skloot GS. Asthma phenotypes and endotypes: a personalized approach to treatment. Current Opinion in Pulmonary Medicine 2016 Jan;22(1):3-9.
14. Brusselle G, Germinaro M, Weiss S, Zangrilli J. Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils. Pulmonary Pharmacology & Therapeutics 2017 Apr;43:39-45.
15. de Roos EW, In ‘t Veen JC, Braunstahl GJ, Lahousse L, Brusselle GG. Targeted therapy for older patients with uncontrolled severe asthma: current and future prospects. Drugs & Aging 2016 Sep;33(9):619-28.
16. Thomas M, Price D, Chrystyn H, Lloyd A, Williams AE, von Ziegenweidt J. Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulmonary Medicine 2009 Jan 2;9:1.
17. Engelkes M, van Blijderveen JC, Overbeek JA, Kuiper J, Herings RCM, Sturkenboom MCJM, de Jongste JC, Verhamme KMC, Janssens HM. Brand and generic use of inhalation medication and frequency of switching in children and adults: a population-based cohort study. Journal of Asthma 2017 Nov 29:1-9.
18. Brüggenjürgen B, Ezzat N, Kardos P, Buhl R. Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment. Allergy 2010 Sep;65(9):1108-15.
19. Chuchalin AG, Viesel AA, Leshchenko IV, Altynbayeva GR, Betaneli TSh, Demko IV, Ilyina EA, Ionova MM, Kashanskaya EP, Kozyreva LS, Kondakova TV, Kornilova TA, Panina NT, Pelevina ID, Petukhova AYu, Sagadeeva EM, Sokolova AV, Ukhanova OP, Tsvetkova OA, Shvareva NYu, Bachinskaya EN. The results of the Russian observational study FREESTYLE (Foradil Combi: efficacy, safety and compliance in patients with bronchial asthma). Atmosphere. Pulmonology and Allergology 2011;2:12-7 (In Russian).
20. Belevskiy AS, Tsvetkova OA. Foradil Combi: efficacy, safety and compliance in patients with bronchial asthma. The results of the national program FREESTYLE 2. Atmosphere. Pulmonology and Allergology 2013;3:29-34 (In Russian).
21. Ciciliani AM, Langguth P, Wachtel H. In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy. International Journal of Chronic Obstructive Pulmonary Disease 2017 May 26;12:1565-77.
22. Kirjavainen M, Mattila L, Vahteristo M, Korhonen J, Lähelmä S. Pharmacokinetics of salmeterol and fluticasone propionate delivered in combination via Easyhaler and Diskus dry powder inhalers in healthy subjects. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2018 Mar 1. doi: 10.1089/jamp.2017.1437. [Epub ahead of print].
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]